Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Re-Time is an Australian sleep-technology and healthcare company that develops and commercializes non-pharmacological wearables for circadian rhythm regulation and sleep improvement. Its flagship products include the retimer series of light-therapy glasses and the retimer Ring, which are positioned to help users manage jet lag, shift-work sleep disruption, insomnia, seasonal affective disorder, and related sleep-health problems. The company originated from Flinders University sleep-science research and has emphasized evidence-based consumer and health-oriented devices rather than therapeutics. Re-Time appears to operate commercially with products on the market and global distribution, and it has been associated with Motherson as an acquired or parent-linked business within a broader health-and-medical wearable portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Re-Time.